Related Experiment Video
Updated: Jan 14, 2026

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
Published on: January 15, 2022
Integrated backscatter intravascular ultrasound features of diffuse coronary artery disease with triglyceride-deposit
Takayuki Nakano1, Hiroki Ikenaga1, Ken-Ichi Hirano2
1Department of Cardiovascular Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University, Japan.
Insights
Triglyceride-deposit cardiomyovasculopathy (TGCV) involves diffuse coronary artery narrowing. This study found TGCV lesions have less lipid area and are linked to worse cardiovascular events in diffuse coronary artery disease patients.
Area of Science:
- Cardiology
- Vascular Biology
- Medical Imaging
Background:
- Triglyceride-deposit cardiomyovasculopathy (TGCV) is defined by diffuse coronary artery narrowing due to atherosclerosis.
- Plaque characteristics and prognosis of TGCV in diffuse coronary artery disease (CAD) are not well understood.
Purpose of the Study:
- To investigate coronary artery morphology in TGCV using integrated backscatter intravascular ultrasound (IB-IVUS).
- To assess the clinical outcomes associated with TGCV in patients with diffuse CAD.
Main Methods:
- Retrospective observational study comparing IB-IVUS findings and clinical outcomes.
- Patients with native coronary lesions of TGCV and non-TGCV with diffuse CAD were analyzed.
- TGCV diagnosis included low BMIPP washout rate (<10%) and diffuse coronary narrowing.
Main Results:
- TGCV lesions showed a significantly smaller lipid area ratio (20% ± 0.8%) compared to non-TGCV lesions (23% ± 0.5%, p=0.02).
- A trend towards a larger calcification area ratio was observed in TGCV.
- The TGCV group experienced significantly higher rates of major adverse cardiovascular events (p=0.01).
Conclusions:
- TGCV in diffuse CAD is characterized by a reduced lipid area in coronary lesions.
- TGCV appears to be associated with poorer clinical outcomes, suggesting a need for early diagnosis and management strategies.
Abstract:
Triglyceride-deposit cardiomyovasculopathy (TGCV) is characterized by diffuse narrowing of the coronary arteries because of triglyceride-deposit atherosclerosis. However, the plaque characteristics and prognosis of TGCV in patients with diffuse coronary artery disease remain unclear. This study aimed to describe the morphology of coronary arteries in TGCV using integrated backscatter intravascular ultrasound (IB-IVUS) and assess the effects on clinical outcomes. This single-center, retrospective observational study compared the IB-IVUS findings and clinical outcomes of patients with native coronary lesions of TGCV with those of patients with non-TGCV, all of whom had diffuse coronary artery disease. TGCV was diagnosed as (1) a low washout rate of iodine-123-β-methyl iodophenyl-pentadecanoic acid (BMIPP; <10%) on BMIPP single-photon emission computed tomography and (2) diffuse narrowing of the coronary arteries on coronary angiography. Thirty-one patients with diffuse coronary artery disease who underwent percutaneous coronary intervention were enrolled. Among these patients 10 (32%) were diagnosed with TGCV. IB-IVUS revealed that TGCV lesions had a significantly smaller ratio of the lipid area than non-TGCV lesions (20% ± 0.8% vs 23% ± 0.5%, p = 0.02). Conversely, the ratio of the calcification area tended to be larger. The Kaplan-Meier analysis revealed a significant increase in the rates of major adverse cardiovascular events in the TGCV group (p = 0.01). Patients with diffuse coronary artery disease present TGCV characterized by a smaller ratio of the lipid area. TGCV might be associated with worse clinical outcomes. The study findings may contribute to its early diagnosis and management.
Related Concept Videos
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Coronary Artery Disease II: Pathophysiology
Atherosclerosis I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies
Coronary Artery Disease III: Clinical Manifestations

